semaglutide and chronic kidney disease Get With the FLOW! in: News Volume 16 Issue 8 (2024) Semaglutide in patients with overweight
Description
This helps people lose weight and feel good about their health
It gained popularity for its once-weekly dosing schedule, something that most other GLP-1 receptor agonists now match
10.3390/ijms21207533 Int
Some people prefer mornings to stay consistent, while others choose evenings if they notice mild fatigue or nausea after dosing
Our findings with semaglutide are based on a CV risk prediction model derived from data from the LEADER CVOT
doi: 10.4158/CS-2017-0153
